Abstract
Cell volumes (equilibrium non-inulin spaces) have been measured in slices of rat cerebral cortex incubated in the presence of uraemic guanidino compounds. Of 5 guanidino compounds tested, all but one caused significant cell swelling. This was most pronounced for guanidinosuccinic acid (GSA, 40 μmol/l)(+22%) and guanidine hydrochloride (G, 3 μmol/l)(+13%). Swelling was reduced by taurine in a dose-dependent manner, being completely abolished at 20 mmol/l. Swelling was also abolished by the antioxidants ascorbic acid (0.4 mmol/l) and butylated hydroxytoluene (0.5 mmol/l), the free radical scavenger N-acetyl-l-cysteine (10 mmol/l) and the lipid peroxidase inhibitor desmethyl tirilazad (100 μmol/l). The remission of swelling by 20 mmol/l taurine was reduced by 50% by the taurine transport inhibitor guanidinoethylsulphonate (GES, 1 mmol/l). This figure was not significantly altered when the concentration of GES was increased to 10 mmol/l. It was also reduced by 45% by the GABA a receptor antagonist bicuculline (100 μmol/l). It was completely abolished when both GES and bicuculline were present. It is suggested that guanidino compounds result in cells undergoing oxidative-nitrosative stress, and that taurine protects against the resultant cell swelling by 2 mechanisms One (intracellular) requires taurine transport and depends on its role as an antioxidant, with lipid peroxidation being probably a significant factor. The other (extracellular) is associated with activation of GABA a receptors.
Similar content being viewed by others
References
S. M. Moe S. M. Sprague (1994) ArticleTitleUremic encephalopathy Clin. Nephrol. 42 251–256 Occurrence Handle7834918 Occurrence Handle1:STN:280:DyaK2M7js1Gnsw%3D%3D
C. L. Fraser A. L. Arieff (1988) ArticleTitleNervous system complications in uremia Annals Int Med. 109 143–153 Occurrence Handle1:STN:280:DyaL1c3ltVOjuw%3D%3D
P. P. Deyn ParticleDe V. K. Saxena H. Abts F. Borggreve R. D’Hooge B. Marescau R. Crols (1992) ArticleTitleClinical and pathophysiological aspects of neurological complications in renal failure Acta Neurol. Belg. 92 191–206 Occurrence Handle1332359
W. H. Horl (1998) ArticleTitleGenesis of the uraemic syndrome: Role of uremic toxins Weiner Klin. Wochen. 110 511–520 Occurrence Handle1:STN:280:DyaK1cvlsFyruw%3D%3D
R. Vanholder et al. (2001) ArticleTitleUremic toxicity: Present state of the art Int. J. Artif. Organs. 24 695–725 Occurrence Handle11817319 Occurrence Handle1:CAS:528:DC%2BD38Xnsl2ltA%3D%3D
R. C. Vanholder G. Glorieux R. Smet ParticleDe P. P. Deyn ParticleDe (2003) ArticleTitleLow water-soluble uremic toxins Adv. Renal Repl. Therap. 10 257–269
R Vanholder et al. (2003) ArticleTitleReview on uremic toxins: Classification, concentration, and interindividual variability Kidney Int. 63 1934–1943 Occurrence Handle12675874 Occurrence Handle1:CAS:528:DC%2BD3sXjslygsbk%3D
R. Vanholder R. Smet ParticleDe (1999) ArticleTitlePathophysiologic effects of uremic retention solutes J. Am. Soc. Nephrol. 10 1815–1823 Occurrence Handle10446951 Occurrence Handle1:CAS:528:DyaK1MXlt1Wqtr8%3D
T. Boure R. Vanholder (2004) ArticleTitleBiochemical and clinical evidence for uremic toxicity Artif. Org. 28 248–253 Occurrence Handle1:CAS:528:DC%2BD2cXktVOkur8%3D
P. P. Deyn ParticleDe R. L. Macdonald (1990) ArticleTitleGuanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses in mouse neurons in cell culture Ann. Neurol. 28 627–633 Occurrence Handle2135950
A. Tanaka Y. Takahashi M. Mizokuchi M. Shimda H. Koide (1999) ArticleTitlePlasma, urinary and electrolyte concentrations of guanidine compounds in patients with chronic renal failure Renal Failure 21 499–514 Occurrence Handle10516995 Occurrence Handle1:STN:280:DyaK1Mvks1WqsA%3D%3D
R. D’Hooge G. Vijver ParticleVan de P.-P. Bogaert ParticleVan B. Marescau R. Vanholder P. P. De Deyn (2003) ArticleTitleInvolvement if voltage- and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic toxins Kidney Int. 63 1764–1775 Occurrence Handle12675852 Occurrence Handle1:CAS:528:DC%2BD3sXjslygsLk%3D
P. P. Deyn ParticleDe P. Robitaille M. Vanasse I. A. Qureshi B. Marescau (1995) ArticleTitleSerum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis Nephron 69 411–417 Occurrence Handle7777105
De Deyn, P. P., Marescau, B., D’Hooge, R., Possemiers, I., Nagler, J., and Mahler, C., 1997. Guanidino compound patterns in uraemic brain. Pages 279–288. in De Deyn, P. P., Marescau, B., Qureshi, I. A., and Mori A. (eds.), Guanidino Compounds:2. John Libbey & Co Ltd
P. P. Deyn ParticleDe R. D’Hooge P.-P. Bogaert ParticleVan B. Marescau (2001) ArticleTitleEndogenous guanidine compounds as uremic neurotoxins Kidney Int. 59 IssueIDSuppl. 78 S77–S83
P. P. Deyn ParticleDe R. Vanholder R. D’Hooge (2003) ArticleTitleNitric oxide in uremia: Effects of several potentially toxic guanidino compounds Kidney Int. 63 IssueIDSuppl. 84), S25–S28
H. Pasantes-Morales A. Schousboe (1997) ArticleTitleRole of taurine in osmoregulation in brain cells: Mechanisms and functional implications Amino Acids 12 281–292 Occurrence Handle10.1007/BF01373008 Occurrence Handle1:CAS:528:DyaK2sXkvFKgs7Y%3D
H. Hagberg A. Lehmann M. Sandberg B. Nystrom I. A. Jacobson And Hamberger (1985) ArticleTitleIschemic-induced shifts of inhibitory and excitatory amino acids in area CA1 of the rat hippocampus Dev. Brain Res. 38 286–290
P. Saransaari S. S. Oja (1998) ArticleTitleMechanisms of ischaemia-induced taurine release in mouse hippocampal slices Brain Res. 807 118–124 Occurrence Handle9757014 Occurrence Handle10.1016/S0006-8993(98)00793-8 Occurrence Handle1:CAS:528:DyaK1cXmtFWitLo%3D
P. Saransaari S. S. Oja (1998) ArticleTitleRelease of endogenous glutamate, aspartate, GABA, and taurine from hippocampal slices from adult and developing mice under cell-damaging conditions Neurochem. Res. 23 563–570 Occurrence Handle9566593 Occurrence Handle10.1023/A:1022494921018 Occurrence Handle1:CAS:528:DyaK1cXislKhu7Y%3D
P. Saransaari S. S. Oja (1999) ArticleTitleCharacteristics of ischaemia-induced taurine release in the developing mouse hippocampus Neuroscience 94 949–954 Occurrence Handle10579587 Occurrence Handle10.1016/S0306-4522(99)00384-X Occurrence Handle1:CAS:528:DyaK1MXmsVWiurc%3D
S. Molchanova P. Koobi S. S. Oja P. Saransaari (2004) ArticleTitleInterstitial concentrations of amino acids in the rat striatum during global forebrain ischaemia and potassium evoked spreading depression Neurochem. Res. 29 1519–1527 Occurrence Handle15260129 Occurrence Handle10.1023/B:NERE.0000029564.98905.5c Occurrence Handle1:CAS:528:DC%2BD2cXksVGms7c%3D
P. Saransaari S. Oja (2000) ArticleTitleTaurine and neural cell damage Amino Acids 19 509–526 Occurrence Handle11140356 Occurrence Handle10.1007/s007260070003 Occurrence Handle1:CAS:528:DC%2BD3MXotFSqsw%3D%3D
S. W. Schaffer J. Azuma J. D. Madura (1995) ArticleTitleMechanisms underlying taurine-mediated alterations in membrane function Amino Acids 8 231–246 Occurrence Handle10.1007/BF00806821 Occurrence Handle1:CAS:528:DyaK2MXnt1Sqt7o%3D
S. Schaffer J. Azuma K. Takahashi M. Mozaffari (2003) ArticleTitleWhy is taurine neuroprotective? Adv. Exp. Med. Biol. 526 307–321 Occurrence Handle12908615 Occurrence Handle1:CAS:528:DC%2BD3sXnsVyhtLk%3D
J. Himmelfarb R. M. Kakim (2003) ArticleTitleOxidative stress in uremia Current Opin. Nephrol. Hyperten. 12 593–598 Occurrence Handle1:CAS:528:DC%2BD2cXkslGqsg%3D%3D
N. D. Vaziri (2003) ArticleTitleOxidative stress in chronic renal failure: Lessons learned from the animal models Blood Purif. 21 328–330
J. Galle S. Seibold. (2003) ArticleTitleHas the time come to use antioxidant therapy in uraemic patients? NephrolDial. Transplant. 18 1452–1455 Occurrence Handle1:CAS:528:DC%2BD3sXmtFKqsrg%3D
M. Prakash S. Upadhya R. Prabhu (2004) ArticleTitleProtein thiol oxidation and lipid peroxidation in patients with uraemia Scand. J. Clin. Lab. Invest. 64 599–604 Occurrence Handle15370466 Occurrence Handle1:CAS:528:DC%2BD2cXntlOlsbo%3D Occurrence Handle10.1080/00365510410002869
Law, R. O. 2005. Taurine protects against the neurotoxic effects of guanidino compounds. Amino Acids. 29:15
R. O. Law (1994) ArticleTitleTaurine efflux and the regulation of cell volume in incubated slices of rat cerebral cortex Biochim. Biophys. Acta 1221 21–28 Occurrence Handle8130273 Occurrence Handle1:CAS:528:DyaK2cXitFeksb8%3D
R. O. Law (1988) ArticleTitleAn inwardly-directed sodium-amino acid cotransporter influences steady-state cell volume in slices of rat renal papilla Incubated in hyperosmotic media Pflug. Arch. 413 43–50 Occurrence Handle10.1007/BF00581227 Occurrence Handle1:CAS:528:DyaL1MXjslSntg%3D%3D
R. J. MacAllister M. H. Rambausek P. Vallence D. Williams K. H. Hoffmann E. Ritz (1996) ArticleTitleConcentration of dimethyl-l-arginine in the plasma of patients with end-stage renal failure Nephrol. Dial. Transplant. 11 2449–2452 Occurrence Handle9017621 Occurrence Handle1:STN:280:DyaK2s7ntVSqsA%3D%3D
S. R. Gullans J. G. Verbalis (1993) ArticleTitleControl of brain volume during hyperosmolar and hypoosmolar conditions Ann. Rev. Med. 44 289–301 Occurrence Handle8476251 Occurrence Handle10.1146/annurev.me.44.020193.001445 Occurrence Handle1:STN:280:DyaK3s3js1elsQ%3D%3D
R. O. Law (1994) ArticleTitleRegulation of mammalian brain cell volume J. Exp. Zool. 268 90–96 Occurrence Handle8301256 Occurrence Handle10.1002/jez.1402680204 Occurrence Handle1:CAS:528:DyaK2cXitFehsL4%3D
H. Pasantes-Morales (1996) ArticleTitleVolume regulation in brain cells: Cellular and molecular mechanisms Metab. Brain Dis. 11 187–204 Occurrence Handle8869940 Occurrence Handle10.1007/BF02237957 Occurrence Handle1:CAS:528:DyaK28Xlslylsr0%3D
B. Brahma R. E. Forman E. E. Stewart C. Nicholson M. E. Rice (2000) ArticleTitleAscorbate inhibits edema in brain slices J. Neurochem. 74 1263–1270 Occurrence Handle10693960 Occurrence Handle1:CAS:528:DC%2BD3cXhtlChtrs%3D
M. Zielinska R. O. Law J. Albrecht (2003) ArticleTitleExcitotoxic mechanism of cell swelling in rat cerebral cortical slices treated acutely with ammonia Neurochem. Int. 43 299–303 Occurrence Handle12742072 Occurrence Handle10.1016/S0197-0186(03)00015-9 Occurrence Handle1:CAS:528:DC%2BD3sXjsVGnt7s%3D
M. K. Shih M. L. Hu (1999) ArticleTitleUVA-induced oxidative damage to rat liver nuclei: reduction of iron ions and the relationship between lipid peroxidation and DNA damage Mutation Res. 438 125–132 Occurrence Handle10036333 Occurrence Handle1:CAS:528:DyaK1MXhslaltw%3D%3D
N. D. Vaziri (2004) ArticleTitleOxidative stress in uraemia: Nature, mechanisms, and potential consequences Semin. Nephrol. 24 469–473 Occurrence Handle15490413 Occurrence Handle1:CAS:528:DC%2BD2cXhtVCgsrfI Occurrence Handle10.1016/j.semnephrol.2004.06.026
M. R. Quinn C. L. Harris (1995) ArticleTitleTaurine allosterically inhibits binding of [35S]-t-butylbicyclophosphorothionate (TBPS) to rat brain synaptic membranes Neuropharmacol. 34 1607–161 Occurrence Handle10.1016/0028-3908(95)00118-2 Occurrence Handle1:CAS:528:DyaK28XhvFGkug%3D%3D
N. Olmo ParticleDel J. Bustamante R. M. Rio ParticleDel J. M. Solis (2000) ArticleTitleTaurine activates GABA A but not GABA B receptors in rat hippocampal CA1 area Brain Res. 864 298–307 Occurrence Handle10802037
B. Mayer (2000) ArticleTitleNitric oxide synthases catalyze superoxide formation FEBS Lett. 481 304 Occurrence Handle11007983 Occurrence Handle10.1016/S0014-5793(00)01998-0 Occurrence Handle1:CAS:528:DC%2BD3cXntFKiu7Y%3D
D. Stuehr S. Pou G. M. Rosen (2001) ArticleTitleOxygen reduction by nitric-oxide synthetase J. Biol. Chem. 276 14533–14536 Occurrence Handle11279231 Occurrence Handle10.1074/jbc.R100011200 Occurrence Handle1:CAS:528:DC%2BD3MXjs1Okt7s%3D
A. Di Biasi R. Di Benedetto S. Salvati L. Attorri F. Leonardi D. Pietraforte (2005) ArticleTitleEffects of L-mono methyl guanidine, N-acreyl arginine, and diphenyleniodonium on free radical release in C6 glial cells enriched in hexacosenoic acid Neurochem. Res. 30 215–223
D. Fliser (2005) ArticleTitleAsymmetric dimethylarginine (ADMA): The silent transition from an ‘uraemic toxin’ to a global cardiovascular risk molecule Eur. J. Clin. Invest. 35 71–79 Occurrence Handle15667575 Occurrence Handle10.1111/j.1365-2362.2005.01457.x Occurrence Handle1:CAS:528:DC%2BD2MXitVKgtbw%3D
Author information
Authors and Affiliations
Corresponding author
Additional information
Special issue dedicated to Simo S. Oja
Rights and permissions
About this article
Cite this article
Law, R.O. Cerebrocellular Swelling in the Presence of Uraemic Guanidino Compounds: Ameliorative Effects of Taurine. Neurochem Res 30, 1465–1470 (2005). https://doi.org/10.1007/s11064-005-8823-y
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11064-005-8823-y